Why menarini Is Trending Today?

Menarini Group, an Italian pharmaceutical company, has announced a strategic partnership with the global biotechnology company, CRISPR Therapeutics AG. The collaboration aims to develop and commercialize CRISPR Therapeutics' gene-editing therapies for various diseases, including sickle cell disease and beta-thalassemia. Under the agreement, Menarini will have exclusive rights to commercialize these therapies in Europe, the Middle East, and Africa.

Menarini Group has announced new data on ELZONRIS® (tagraxofusp-erzs), which will be presented at the 67th annual meeting of the American Society of Hematology. The Menarini Group's ice hockey team, Les Volpi Rosse Menarini, has prepared their "Fantastic Ten" lineup for the 2025-2026 season.